Cancer trials

This study focuses on a form of blood cancer called lymphoma, the most common subtype of which is Diffuse Large B Cell Lymphoma (DLBCL). DLBCL is curable with chemotherapy in approximately 60% of patients. However, 40% of patients either fail to…

Melanoma is the most lethal form of skin cancer: over 13,000 patients are diagnosed in the United Kingdom (UK) annually. Although the majority of patients are diagnosed with primary tumours that can be removed by surgery, around 20% will relapse…

Breast cancer is the most common female cancer worldwide, and the second most common cancer overall, with more than 1,676,000 newly diagnosed in 2012 (25% of female cancer cases and 12% of the total). Although advances in screening, surgical…

Treatment for melanoma patients is rapidly evolving, as new systemic therapies are improving outcomes in both the metastatic and adjuvant setting. Three key international randomised trials evaluating both immune checkpoint inhibitors and…